These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 11478142

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Two cases of endometrial stromal sarcoma (ESS) in which survival was prolonged by administration of MPA].
    Ishibashi M, Nakayama K, Shamima Y, Katagiri A, Iida K, Nakayama N, Miyazaki K.
    Gan To Kagaku Ryoho; 2008 May; 35(5):857-61. PubMed ID: 18487930
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of recurrent uterine endometrial cancer in adjuvant therapy with medroxyprogesterone acetate (MPA) in addition of etoposide].
    Ishizaki T, Yamamoto T, Itoh R, Yasuda J, Fujita H, Okada H.
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):137-40. PubMed ID: 7826070
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
    Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C.
    Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
    [Abstract] [Full Text] [Related]

  • 7. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
    Mitsushita J, Toki T, Kato K, Fujii S, Konishi I.
    Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sparing fertility in young patients with endometrial cancer.
    Chiva L, Lapuente F, González-Cortijo L, Carballo N, García JF, Rojo A, Gonzalez-Martín A.
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
    Gadducci A, Cosio S, Genazzani AR.
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
    [Abstract] [Full Text] [Related]

  • 13. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
    Hurst SA, Hartzfeld KM, Del Priore G.
    Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A patient with stage 1a endometrial carcinoma in whom a solitary recurrent lesion was detected in the external iliac lymph node after MPA therapy.
    Takahashi N, Hirashima Y, Harashima S, Takekuma M, Kawaguchi R, Yamada Y, Ito I.
    Arch Gynecol Obstet; 2008 Oct; 278(4):365-7. PubMed ID: 18273628
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.